News

The Biotechnology Organization and MichBio support Governor Rick Snyder for signing critical legislation to pave way for the substitution of Interchangeable biologic medicines conveying…
Read More...

CSA medical declared the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating Chronic Bronchitis Patients (NCT02483637).…
Read More...

JHL Biotech has asserted that the Dutch Healthcare Authority has sanctioned a Clinical Trial Application for JHL's dornase alfa biosimilar, JHL1922 to enhance pulmonary function of…
Read More...

Ionis Pharmaceuticals which is a leader in antisense therapeutics asserted that the positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx      in people with early…
Read More...

Ageless Forever asserts to offer GAINSWave which is an innovative noninvasive medical therapy that utilizes low-intensity shockwave therapy to treat Erectile Dysfunction symptoms. It…
Read More...

Regeneron Pharmaceuticals and Sanofi claimed that the U.S Food and Drug Administration has considered to assess the supplemental Biologics License Application (sBLA) of DUPIXENT as an…
Read More...

Mylan set to introduce two new HIV treatments namely, Symfi Lo and Cimduo that was sanctioned in February by the U.S Food and Drug Administration. Introducing Symfi Lo in the coming…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...

Cook Medical affirmed the leaders of its two new business divisions. Mark Breedlove has been named vice president of Cook’s Vascular division and DJ Sirota has been named vice president…
Read More...

Sonex Health has claimed a co-marketing agreement with Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. This relationship will position Sonex…
Read More...

Concert Pharmaceuticals asserted the next development candidate CTP-692, a novel drug for adjunctive treatment of schizophrenia, a devastating, chronic illness with significant unmet…
Read More...

U.S Food and Drug Administration ensures that patients and providers have timely and continued access to safe, effective, and high-quality medical products. FDA’s Center for Drug…
Read More...

Blink Health asserted the appointment of Former Kayak Chief Architect and General Manager of Mobile Bill O’Donnell to lead its engineering team. O’Donnell will serve as Executive Vice…
Read More...

Apnea Sciences Corporation asserted the availability of SnoreRx at selected CVS pharmacies. FDA has sanctioned SnoreRx to be denoted as the first and only oral appliance for treatment…
Read More...

The Kinetix Group Care Delivery Services has launched a Real World Evidence model,focusing on diabetes and cardiovascular conditions. As a part of this initiative, we have partnered…
Read More...

MAIA Pharmaceuticals, NJ based specialty pharmaceutical company asserted tentative approval of Sincalide for Injection NDA by the U.S. Food and Drug Administration. As far as 2013 is…
Read More...

BioAtla which is a global biotechnology company aiming to develop Conditionally Active Biologic protein Therapeutics announced the treatment of first patient in its clinical trial…
Read More...

Sangamo Therapeutics declared that the Medicines and Healthcare Products Regulatory Agency of the United Kingdom has extended Clinical Trial Authorization for enlisting subjects into…
Read More...

MabVax Therapeutics , a clinical-stage biotechnology company that aims to develop antibody-based products to address unattainable medical needs to treat cancer declared positive results…
Read More...

Second Genome which is considered a leader in the development of novel medicines derived from the human microbiome initiated four collaborations with key academic institutions to assess…
Read More...